{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "2771426",
  "DateCompleted": {
    "Year": "1989",
    "Month": "09",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0141-9838",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "3",
        "PubDate": {
          "Year": "1989",
          "Month": "May"
        }
      },
      "Title": "Parasite immunology",
      "ISOAbbreviation": "Parasite Immunol"
    },
    "ArticleTitle": "Development of metacyclic Leishmania promastigotes is associated with the increasing expression of GP65, the major surface antigen.",
    "Pagination": {
      "StartPage": "197",
      "EndPage": "209",
      "MedlinePgn": "197-209"
    },
    "Abstract": {
      "AbstractText": [
        "Using immunofluorescence techniques and flow microfluorometry analysis, we have demonstrated that the binding of a monoclonal antibody (VD5/25) produced against GP65, the major surface antigen of Leishmania braziliensis, increased on the surface of stationary-phase promastigotes from all the New World Leishmania species causing mucocutaneous or cutaneous disease as compared with the log-phase parasites. In addition, a sequential development of Leishmania amazonensis promastigotes from a non-infective to an infective stage was demonstrated. Indeed, promastigotes in the stationary phase (days 6-7) were found to be far more infective than those in the logarithmic phase of growth (day 3) both in vitro for mouse peritoneal macrophages and in vivo for BALB/c mice. The intracellular survival and multiplication of L. amazonensis were significantly inhibited when infective promastigotes were treated with the VD5/25 monoclonal antibody. The increasing expression of GP65 on the promastigote surface may thus contribute to Leishmania infectivity. This seems to represent a characteristic mechanism applicable to all New World Leishmania species studied."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre d'Immunologie et de Biologie Parasitaire, Unit\u00e9 Mixte INSERM U167-CNRS-624, Institut Pasteur, Lille, France."
          }
        ],
        "LastName": "Kweider",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lemesre",
        "ForeName": "J L",
        "Initials": "JL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Santoro",
        "ForeName": "F",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kusnierz",
        "ForeName": "J P",
        "Initials": "JP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sadigursky",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Capron",
        "ForeName": "A",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Parasite Immunol",
    "NlmUniqueID": "7910948",
    "ISSNLinking": "0141-9838"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Monoclonal"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Protozoan"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Surface"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Monoclonal"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Antigens, Protozoan"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Antigens, Surface"
    },
    {
      "QualifierName": [
        "growth & development",
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "Leishmania"
    },
    {
      "QualifierName": [
        "immunology",
        "parasitology"
      ],
      "DescriptorName": "Leishmaniasis"
    },
    {
      "QualifierName": [
        "immunology",
        "parasitology"
      ],
      "DescriptorName": "Leishmaniasis, Mucocutaneous"
    },
    {
      "QualifierName": [
        "parasitology"
      ],
      "DescriptorName": "Macrophages"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Inbred BALB C"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virulence"
    }
  ]
}